Part 4/8:
A significant concern raised during the discourse was the lack of a dedicated research institute in Nigeria focusing on Ebola and related infectious diseases. Although there are available vaccines for Ebola, they are predominantly tailored to endemic countries such as Uganda and the Democratic Republic of the Congo, with limited provisions available in Nigeria.
Current efforts in vaccine rollout and clinical research have occurred outside Nigeria, showcasing the critical need for strengthening local capacities. Professor Isaku underscored the necessity of a coordinated national research agenda that not only addresses current viral threats but also prepares for future outbreaks.